THC Therapeutics, Inc. reported earnings results for the first quarter ended October 31, 2022. For the first quarter, the company reported net loss was USD 2.13 million compared to USD 0.486437 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.02 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0033 USD | +3.12% | +3.12% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 133K | |
-0.98% | 108B | |
+16.65% | 4.44B | |
+1.22% | 3.95B | |
+30.34% | 2.83B | |
+65.73% | 2.23B | |
-7.18% | 1.29B | |
-1.33% | 698M | |
+98.57% | 595M | |
+39.64% | 552M |
- Stock Market
- Equities
- THCT Stock
- News THC Therapeutics, Inc.
- THC Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2022